Download full-text PDF

Source
http://dx.doi.org/10.1016/s1051-0443(07)61380-3DOI Listing

Publication Analysis

Top Keywords

percutaneous thrombin
4
thrombin injection
4
injection splanchnic
4
splanchnic artery
4
artery aneurysms
4
aneurysms case
4
case reports
4
percutaneous
1
injection
1
splanchnic
1

Similar Publications

Purpose: In this study, we aimed to assess the occurrence of hidden blood loss (HBL) and its associated risk factors in patients with lumbar degenerative diseases who underwent percutaneous endoscopic transforaminal lumbar interbody fusion (Endo-TLIF).

Methods: Sex, age, height, weight, body mass index, and medical history including hypertension, diabetes, and osteoporosis were recorded. The duration of symptoms, preoperative lumbar subcutaneous fat tissue thickness (measured using midsagittal T2-weighted magnetic resonance imaging), lumbar disc degeneration grade, and other basic patient information were also documented.

View Article and Find Full Text PDF

Balloon-assisted percutaneous thrombin injection in a subclavian artery pseudoaneurysm: A case report.

Radiol Case Rep

March 2025

Department of Medical Imaging, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Jeddah, Saudi Arabia.

Subclavian artery pseudoaneurysm (SAP) is a rare but lethal diagnosis, and an important condition that should be detected and managed imperatively. SAP has been seldom described in the literature, explaining the lack of concrete management guidelines. Herein we present a case study of a 63-year-old man with SAP post a transcatheter aortic valve implantation (TAVI) done 8 days prior to current presentation.

View Article and Find Full Text PDF

Pseudoaneurysms develop as a result of disruption of the arterial wall due to trauma or iatrogenic reasons such as catheterization, and it is important due to the high risk of bleeding and rupture. Until recently, the main treatment of pseudoaneurysms was surgical repair. However, in recent years, minimally invasive methods such as ultrasound-guided compression and percutaneous thrombin injection have been used more frequently.

View Article and Find Full Text PDF
Article Synopsis
  • STEMI is typically triggered by a ruptured plaque, leading to blood clot formation, and treatments like platelet inhibitors and PCI are crucial for recovery.
  • This study, part of the VALIDATE-SWEDHEART trial, analyzed 89 STEMI patients to examine how morphine, used for pain relief, affects platelet activity after treatment with ticagrelor and primary PCI.
  • Results indicated that morphine treatment was associated with higher platelet aggregation one hour after PCI, but did not impact inflammation biomarkers or show significant differences before or twelve hours post-PCI.
View Article and Find Full Text PDF
Article Synopsis
  • Residual shunt (RS) after percutaneous patent foramen ovale (PFO) closure remains controversial regarding its link to subsequent ischemic events, requiring consideration of various injury mechanisms.
  • Biochemical evidence suggests that successful PFO closure significantly reduces levels of molecules (like serotonin and homocysteine) associated with stroke risk, aligning the blood composition of patients post-procedure with that of healthy individuals.
  • The review highlights the variability in study findings due to differences in populations, assessment methods, and follow-up duration, with recent guidelines identifying RS as a potential predictor for ischemic event recurrence, emphasizing the need for further research in this area.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!